Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' PERRY KW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 35 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Cartmell, J; Perry, KW; Salhoff, CR; Monn, JA; Schoepp, DD
      Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade

      NEUROPHARMACOLOGY
    2. Du, YS; Ma, ZZ; Lin, SZ; Dodel, RC; Gao, F; Bales, KR; Triarhou, LC; Chernet, E; Perry, KW; Nelson, DLG; Luecke, S; Phebus, LA; Bymaster, FP; Paul, SM
      Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    3. Tzavara, ET; Perry, KW; Rodriguez, DE; Bymaster, FP; Nomikos, GG
      The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrineoutflow in the rat anterior hypothalamus

      EUROPEAN JOURNAL OF PHARMACOLOGY
    4. Perry, KW; Nisenbaum, LK; George, CA; Shannon, HE; Felder, CC; Bymaster, FP
      The muscarinic agonist xanomeline increases monoamine release and immediate early gene expression in the rat prefrontal cortex

      BIOLOGICAL PSYCHIATRY
    5. Zhang, W; Perry, KW; Wong, DT; Potts, BD; Bao, JQ; Tollefson, GD; Bymaster, FP
      Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

      NEUROPSYCHOPHARMACOLOGY
    6. Cartmell, J; Perry, KW; Salhoff, CR; Monn, JA; Schoepp, DD
      The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat

      JOURNAL OF NEUROCHEMISTRY
    7. Cartmell, J; Salhoff, CR; Perry, KW; Monn, JA; Schoepp, DD
      Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum

      BRAIN RESEARCH
    8. Gronier, B; Perry, KW; Rasmussen, K
      Activation of the mesocorticolimbic dopaminergic system by stimulation of muscarinic cholinergic receptors in the ventral tegmental area

      PSYCHOPHARMACOLOGY
    9. Bymaster, F; Perry, KW; Nelson, DL; Wong, DT; Rasmussen, K; Moore, NA; Calligaro, DO
      Olanzapine: a basic science update

      BRITISH JOURNAL OF PSYCHIATRY
    10. SHANNON HE; BYMASTER FP; BODICK NW; OFFEN WW; DELAPP NC; PERRY KW; RASMUSSEN K; WARD JS; WHITESITT CA; FINKJENSEN A; OLESEN P; RASMUSSEN T; SHEARDOWN M; SWEDBERG M; SAUERBERG P
      MUSCARINIC AGENTS - A NEW APPROACH TO THE TREATMENT OF PSYCHOSIS

      Schizophrenia research
    11. ZHANG W; PERRY KW; BYMASTER FP
      IN-VIVO EFFECTS OF OLANZAPINE ON RADIOLIGAND BINDING, DOPAMINE D2 AUTORECEPTOR BLOCKADE, AGONIST-INDUCED IN-VIVO PHOSPHOINOSITIDE HYDROLYSIS AND NEUROTRANSMITTER RELEASE

      Schizophrenia research
    12. LI XM; PERRY KW; WONG DT; BYMASTER FP
      OLANZAPINE INCREASES IN-VIVO DOPAMINE AND NOREPINEPHRINE RELEASE IN RAT PREFRONTAL CORTEX, NUCLEUS-ACCUMBENS AND STRIATUM

      Psychopharmacology
    13. BYMASTER FP; LI XM; CARTER PA; WONG DT; PERRY KW
      OLANZAPINE INCREASES EXTRACELLULAR DOPAMINE RELEASE AND BLOCKS DOPAMINE, SEROTONIN AND MUSCARINIC RECEPTORS IN-VIVO

      Schizophrenia research
    14. PERRY KW; FULLER RW
      FLUOXETINE INCREASES NOREPINEPHRINE RELEASE IN RAT HYPOTHALAMUS AS MEASURED BY TISSUE-LEVELS OF MHPG-SO4 AND MICRODIALYSIS IN CONSCIOUS RATS

      Journal of neural transmission
    15. FERRIS CF; MELLONI RH; KOPPEL G; PERRY KW; FULLER RW; DELVILLE Y
      VASOPRESSIN SEROTONIN INTERACTIONS IN THE ANTERIOR HYPOTHALAMUS CONTROL AGGRESSIVE-BEHAVIOR IN GOLDEN-HAMSTERS/

      The Journal of neuroscience
    16. HUANG NY; KOSTRZEWA RM; LI CF; PERRY KW; FULLER RW
      PERSISTENT SPONTANEOUS ORAL DYSKINESIAS IN HALOPERIDOL-WITHDRAWN RATSNEONATALLY LESIONED WITH 6-HYDROXYDOPAMINE - ABSENCE OF AN ASSOCIATION WITH THE B-MAX FOR [H-3] RACLOPRIDE BINDING TO NEOSTRIATAL HOMOGENATES

      The Journal of pharmacology and experimental therapeutics
    17. DRESHFIELD LJ; WONG DT; PERRY KW; ENGLEMAN EA
      ENHANCEMENT OF FLUOXETINE-DEPENDENT INCREASE OF EXTRACELLULAR SEROTONIN (5-HT) LEVELS BY (-)-PINDOLOL, AN ANTAGONIST AT 5-HT1A RECEPTORS

      Neurochemical research
    18. BELL SL; PERRY KW; ROWLINSON P
      CONTROL OF GASTROINTESTINAL PARASITISM IN CALVES WITH ALBENDAZOLE DELIVERED VIA AN INTRARUMINAL CONTROLLED-RELEASE DEVICE

      Veterinary parasitology
    19. KOSTRZEWA RM; BRUS R; PERRY KW; FULLER RW
      DOPAMINE AND 5-HT RECEPTOR SENSITIVITY DOES NOT CORRELATE WITH NEOSTRIATAL DOPAMINE OR 5-HT CONTENT

      Acta Neurobiologiae Experimentalis
    20. LI XM; PERRY KW; FULLER RW
      ON THE IN-VIVO MODULATION OF NEOSTRIATAL DOPAMINE RELEASE BY FLUOXETINE AND 5-HYDROXY-L-TRYPTOPHAN IN CONSCIOUS RATS

      Journal of Pharmacy and Pharmacology
    21. FULLER RW; PERRY KW; HEMRICKLUECKE SK; ENGLEMAN E
      SERUM CORTICOSTERONE INCREASES REFLECT ENHANCED UPTAKE INHIBITOR-INDUCED ELEVATION OF EXTRACELLULAR 5-HYDROXYTRYPTAMINE IN RAT HYPOTHALAMUS

      Journal of Pharmacy and Pharmacology
    22. ENGLEMAN EA; ROBERTSON DW; THOMPSON DC; PERRY KW; WONG DT
      ANTAGONISM OF SEROTONIN 5-HT1A RECEPTORS POTENTIATES THE INCREASES INEXTRACELLULAR MONOAMINES INDUCED BY DULOXETINE IN RAT HYPOTHALAMUS

      Journal of neurochemistry
    23. BYMASTER FP; HEMRICKLUECKE SK; PERRY KW; FULLER RW
      NEUROCHEMICAL EVIDENCE FOR ANTAGONISM BY OLANZAPINE OF DOPAMINE, SEROTONIN, ALPHA(1)-ADRENERGIC AND MUSCARINIC RECEPTORS IN-VIVO IN RATS

      Psychopharmacology
    24. BYMASTER FP; FALCONE JF; HEMRICKLUECKE SK; PERRY KW; FULLER RW
      THE ATYPICAL ANTIPSYCHOTIC OLANZAPINE BLOCKS MUSCARINIC, SEROTONERGICAND DOPAMINE-RECEPTORS

      Schizophrenia research
    25. ENGLEMAN EA; PERRY KW; MAYLE DA; WONG DT
      SIMULTANEOUS INCREASES OF EXTRACELLULAR MONOAMINES IN MICRODIALYSATESFROM HYPOTHALAMUS OF CONSCIOUS RATS BY DULOXETINE, A DUAL SEROTONIN AND NOREPINEPHRINE UPTAKE INHIBITOR

      Neuropsychopharmacology
    26. FULLER RW; SNODDY HD; PERRY KW
      TISSUE DISTRIBUTION, METABOLISM AND EFFECTS OF BUFOTENINE ADMINISTERED TO RATS

      Neuropharmacology
    27. PERRY KW; KOSTRZEWA RM; FULLER RW
      PERSISTENCE OF LONG-LASTING SEROTONIN DEPLETION BY P-CHLOROAMPHETAMINE IN RAT-BRAIN AFTER 6-HYDROXYDOPAMINE LESIONING OF DOPAMINE NEURONS

      Biochemical pharmacology
    28. PERRY KW; JANES AN; WEEKES TEC; PARKER DS; ARMSTRONG DG
      GLUCOSE AND L-LACTATE METABOLISM IN PREGNANT AND IN LACTATING EWES FED BARLEY-BASED OR GROUND MAIZE-BASED DIETS

      Experimental physiology
    29. WONG DT; PERRY KW; ENGLEMAN EA
      DULOXETINE ELEVATES EXTRACELLULAR SEROTONIN (5-HT) AND NOREPINEPHRINE(NE) IN HYPOTHALAMUS IN-VIVO

      The FASEB journal
    30. KOSTRZEWA RM; BRUS R; KALBFLEISCH JH; PERRY KW; FULLER RW
      PROPOSED ANIMAL-MODEL OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER

      Brain research bulletin
    31. GONG L; KOSTRZEWA RM; PERRY KW; FULLER RW
      DOSE-RELATED EFFECTS OF A NEONATAL 6-OHDA LESION ON SKF 38393- AND M-CHLOROPHENYLPIPERAZINE-INDUCED ORAL ACTIVITY RESPONSES OF RATS

      Developmental brain research
    32. GONG L; KOSTRZEWA RM; BRUS R; FULLER RW; PERRY KW
      ONTOGENIC SKF 38393 TREATMENTS SENSITIZE DOPAMINE-D(1) RECEPTORS IN NEONATAL 6-OHDA-LESIONED RATS

      Developmental brain research
    33. KOSTRZEWA RM; BRUS R; PERRY KW; FULLER RW
      AGE-DEPENDENCE OF A 6-HYDROXYDOPAMINE LESION ON SKF 38393-CHLOROPHENYLPIPERAZINE-INDUCED AND M-CHLOROPHENYLPIPERAZINE-INDUCED ORAL ACTIVITYRESPONSES OF RATS

      Developmental brain research
    34. PERRY KW; FULLER RW
      EXTRACELLULAR 5-HYDROXYTRYPTAMINE CONCENTRATION IN RAT HYPOTHALAMUS AFTER ADMINISTRATION OF FLUOXETINE PLUS L-5-HYDROXYTRYPTOPHAN

      Journal of Pharmacy and Pharmacology
    35. HENDERSON MG; PERRY KW; FULLER RW
      POSSIBLE INVOLVEMENT OF DOPAMINE IN THE LONG-TERM SEROTONIN DEPLETIONBY P-CHLOROAMPHETAMINE AND BETA,BETA-DIFLUORO-P-CHLOROAMPHETAMINE IN RATS

      The Journal of pharmacology and experimental therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 23:08:37